Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept & continue
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • G7 to explore caps on energy prices to curb Russian revenues
    • Boris Johnson wins Commons vote on bill to rip up N Ireland protocol
    • Nato to increase forces on high alert to 300,000
    • Russia claims responsibility for Kremenchuk mall strike
    • Russian missile strike on Ukrainian shopping mall draws outcry
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • G7 to explore caps on energy prices to curb Russian revenues
    • Why the US could be the real winner in the energy wars
    • ‘We will humble them’: four fuel traders took on Wall Street and saved $1.2bn
    • Donald Trump’s plans for Spac deal suffer further blow after subpoenas
    • US company spending on private jets for personal use hits 10-year high
  • Companies
    Sections
    • Companies Home
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
    Most Read
    • Luxottica founder Leonardo Del Vecchio dies aged 87
    • ‘We will humble them’: four fuel traders took on Wall Street and saved $1.2bn
    • Donald Trump’s plans for Spac deal suffer further blow after subpoenas
    • US company spending on private jets for personal use hits 10-year high
    • ExxonMobil chief predicts continuing surge in oil markets
  • Tech
  • Markets
    Sections
    • Markets Home
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
    Most Read
    • Live news updates: US to announce new military commitments during Nato summit
    • ‘We will humble them’: four fuel traders took on Wall Street and saved $1.2bn
    • France’s approval of crypto exchange Binance branded ‘incomprehensible’ by MEP
    • Live news updates from June 27: G7 to impose new sanctions on Russian arms industry, Property developer Evergrande faces winding-up petition
    • Time is ripe to snap up bargains, says debt investor Howard Marks
  • Climate
  • Opinion
    Sections
    • Opinion Home
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
    Most Read
    • Young men are slipping quietly through the economy’s cracks
    • Why the US could be the real winner in the energy wars
    • The high cost of producing cheap food
    • Crisis looms if the ECB’s new tool comes up short
    • Grim times lie ahead for UK as inflation combines with low growth
  • Work & Careers
    Sections
    • Work & Careers Home
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
    Most Read
    • What’s a good (and bad) way to leave your job?
    • If you want to be more likeable, try showing more stress
    • ‘Exactly how much virtue do you really want to signal?’
    • JSR’s Eric Johnson: ‘I encourage people to tell me exactly how they think’
  • Life & Arts
    Sections
    • Life & Arts Home
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
    Most Read
    • Inside the secret, often bizarre world that decides what porn you see
    • What can the past tell us about Bitcoin’s future?
    • The future of farming: how to feed a troubled world
    • A pilot’s guide to beating jet lag
    • Sunday at Glastonbury — a next-level performance from Kendrick Lamar closes the festival
  • HTSI
MenuSearch
  • Home
  • World
  • US
  • Companies
  • Tech
  • Markets
  • Climate
  • Opinion
  • Work & Careers
  • Life & Arts
  • HTSI
Financial Times
SubscribeSign In

Your guide to a disrupted world

Start a 4-week trial

Samsung BioLogics

Add to myFT Digest

Add this topic to your myFT Digest for news straight to your inbox

  • Monday, 21 March, 2022
    Samsung Biologics capitalises on pandemic boom to expand in US and Europe

    South Korean group makes Covid-19 treatments for the UK’s GSK and AstraZeneca

  • Wednesday, 1 July, 2020
    LexJune Yoon
    Lex Letter from Seoul: facing the facts Premium content

    South Korean biotech stocks have been a favourite of retail investors even before the pandemic

  • Tuesday, 11 June, 2019
    Samsung Electronics Co Ltd
    Samsung heir’s top aide questioned over suspected cover-up

    Prosecutors grill Samsung Electronics president Chung Hyun-ho over alleged $3.9bn fraud

  • Thursday, 16 May, 2019
    Samsung Electronics Co Ltd
    Samsung fraud probe widens to battle for chaebol succession

    South Korean prosecutors say staff were ordered to destroy or conceal data

  • Monday, 29 April, 2019
    Samsung Group
    Two Samsung employees arrested over alleged cover-up

    The staff of Samsung biopharmaceutical unit are accused of destroying evidence

  • Tuesday, 11 December, 2018
    Samsung BioLogics surges by a fifth after avoiding delisting

    Stock exchange to monitor company’s efforts to boost management transparency for 3 years

  • Tuesday, 11 December, 2018
    Samsung BioLogics surges after avoiding delisting
  • Wednesday, 14 November, 2018
    Possible delisting of BioLogics threatens Samsung’s growth strategy

    High-growth drugs unit represented group’s best effort to diversify out of electronics

  • Wednesday, 14 November, 2018
    Samsung BioLogics violated accounting rules, says watchdog

    The company is accused of having inflated the value of an affiliate group

  • Thursday, 12 July, 2018
    Accountancy
    Samsung BioLogics breached accounting rules, watchdog rules

    South Korean regulator says biopharma company dropped crucial information on joint venture

  • Thursday, 12 July, 2018
    Pharmaceuticals sector
    Korean regulator rules Samsung BioLogics violated accounting rules

    BioLogics changed the way it valued its stake in drugmaker Samsung Bioepis in 2015

  • Wednesday, 2 May, 2018
    LexAccountancy
    Samsung BioLogics: hidden in plain sight Premium content

    Regulators are right to investigate but biotech company can make a good case for the defence

  • Wednesday, 2 May, 2018
    Accountancy
    Regulator says Samsung BioLogics breached accounting rules

    Shares in biopharma unit down by as much as 20%

  • Wednesday, 2 May, 2018
    Accountancy
    Samsung BioLogics tumbles after accounting breach ruling
  • Friday, 12 August, 2016
    IPOs
    Samsung biopharma unit lines up South Korea IPO

    Biologics listing expected to raise Won2tn-Won3tn as parent group’s main growth driver

Previous page You are on page 1 Next page

Useful links

Support

View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

Legal & Privacy

Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

Services

Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT TransactSecondary Schools

Tools

PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

Community & Events

FT CommunityFT LiveFT ForumsFT Board DirectorBoard Director Programme

More from the FT Group

Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2022. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
Financial Times

International Edition

Subscribe for full access
  • Switch to UK Edition
  • Top sections
  • Home
  • World
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
  • US
    • US Economy
    • US Companies
    • US Politics & Policy
  • Companies
    • Energy
    • Financials
    • Health
    • Industrials
    • Media
    • Professional Services
    • Retail & Consumer
    • Tech Sector
    • Telecoms
    • Transport
  • Tech
  • Markets
    • Alphaville
    • Markets Data
    • Capital Markets
    • Commodities
    • Currencies
    • Equities
    • Fund Management
    • Trading
    • Moral Money
    • ETF Hub
    • Cryptocurrencies
  • Climate
  • Opinion
    • Columnists
    • The FT View
    • The Big Read
    • Lex
    • Obituaries
    • Letters
  • Work & Careers
    • Business School Rankings
    • Business Education
    • Entrepreneurship
    • Recruitment
    • Business Books
    • Business Travel
  • Life & Arts
    • Arts
    • Books
    • Food & Drink
    • FT Magazine
    • House & Home
    • Style
    • Travel
    • FT Globetrotter
  • Personal Finance
    • Property & Mortgages
    • Investments
    • Pensions
    • Tax
    • Banking & Savings
    • Advice & Comment
    • Next Act
  • HTSI
  • Special Reports
  • FT recommends
  • Lex
  • Alphaville
  • Lunch with the FT
  • FT Globetrotter
  • #techAsia
  • Moral Money
  • FTfm
  • Newsletters
  • Video
  • Podcasts
  • News feed
  • FT Community
    • FT Live
    • FT Forums
    • Board Director Programme
  • myFT
  • Portfolio
  • Today's Newspaper (ePaper)
  • Crossword
  • Our Apps
  • Help Centre
  • Subscribe
  • Sign In